Clinical Trials Browser

Phase 2 × isoquercitrin × 90 days × Clear all

NCT07303894 2026-01-29

A Study of Isoquercetin in People With Ovarian Cancer

Phase 2 Recruiting

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms